Description
Description
This page contains brief details about the drug cabozantinib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Cabozantinib is a targeted anticancer treatment drug that was approved for its medical use on November 2012.
Mechanism of Action of Cabozantinib
Cabozantinib is a biological agent that acts as targeted drug therapy in cancer treatment. It is an anticancer medication that belongs to the category of tyrosine kinase inhibitors. It acts against protein called receptor tyrosine kinases and interferes with cell signalling, ultimately stopping the growth and spread of cancer cells. Cabozantinib is indicated alone or in combination with Nivolumab.
Uses of Cabozantinib
Cabozantinib has been developed to treat a type of liver cancer (hepatocellular carcinoma), differentiated thyroid cancer in patients who are ineligible for radioactive iodine therapy and kidney cancer (Renal cell carcinoma) after disease progression and inadequate response to other anticancer therapies.
Cabozantinib Dosage available
Cabozantinib is available in the form of film-coated tablets in the doses 20mg and 60mg. Take Cabozantinib Tablet an hour before food or two hours after meals. Swallow the tablet whole with a glass of water and do not crush or chew them.
